StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
Management ChangeMay 14, 2026, 04:32 PM

MeiraGTx Grants Equity Awards to New Chief Development Officer

AI Summary

MeiraGTx Holdings plc announced that its Compensation Committee approved equity awards for Penny Fleck in connection with her employment as Chief Development Officer. These awards were granted as an inducement material to her new employment, in accordance with Nasdaq Listing Rule 5635(c)(4). Ms. Fleck received non-qualified stock options to purchase 100,000 shares at an exercise price of $9.97, and 100,000 time-based restricted stock units (RSUs).

Key Highlights

  • MeiraGTx granted equity awards to Penny Fleck, the new Chief Development Officer.
  • Awards were an inducement for Ms. Fleck's employment, per Nasdaq Listing Rule 5635(c)(4).
  • Ms. Fleck received non-qualified stock options to purchase 100,000 ordinary shares.
  • The exercise price for the stock options is $9.97 per share.
  • Stock options vest 25% on the first anniversary, then monthly over 36 months.
  • Ms. Fleck also received 100,000 time-based restricted stock units (RSUs).
  • RSUs vest 50% on the second anniversary, 25% on the third, and 25% on the fourth anniversary.